Status:
UNKNOWN
Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix.
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Cervical Intraepithelial Neoplasia Grade 1 (CIN 1)
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
P16INK4a has recently been described as a surrogate marker for HR-HPV associated squamous and glandular intraepithelial lesions of the cervix. The immunohistochemical staining pattern of p16INK4a in h...
Eligibility Criteria
Inclusion
- Responsible women \> 18 years with histologically proven CIN 1
Exclusion
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00343213
Start Date
June 1 2006
Last Update
August 30 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Gynécologie-Obstétrique - Centre Hospitalier Général
Haguenau, France
2
Service de gynécologie-obtétrique - Centre Hospitalier Général
Saverne, France
3
Département de Gynécologie-Obstétrique - Hôpital de Hautepierre
Strasbourg, France, 67098